FindTrial
Sign In

An observational study of intestinal CRE screening in patients with hematologic malignancies with high risk factors for treatment decisions

An observational study of intestinal CRE screening in patients with hematologic malignancies with high risk factors for treatment decisions

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039074
Enrollment
Unknown
Registered
2020-10-15
Start date
2020-09-30
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic malignancy

Interventions

No Group:No intervention

Sponsors

Xiangya Third Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 90 Years

Inclusion criteria

Inclusion criteria: All patients with malignant tumor of the hematology department.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
CRE screening results;—

Countries

China

Contacts

Public ContactLi Xin

Xiangya Third Hospital of Central South University

lixiner1975@163.com+86 13808418932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026